These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 1037483)

  • 41. [Treatment of acromegaly with bromocriptine (CB 154)].
    Schwinn G; Dirks H; Köbberling J
    Verh Dtsch Ges Inn Med; 1976; 82 Pt 2():1896-9. PubMed ID: 801095
    [No Abstract]   [Full Text] [Related]  

  • 42. Assessment of hypokinesia in Parkinsonism.
    Teräväinen H; Calne DB
    J Neural Transm; 1981; 51(1-2):149-59. PubMed ID: 7021768
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Cross tolerance between two dopaminergic ergot derivatives--bromocriptine and lergotrile.
    Teychenne PF; Rosin AJ; Plotkin CN; Calne DB
    Br J Clin Pharmacol; 1980 Jan; 9(1):47-50. PubMed ID: 6101955
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Bromocriptine in migraine.
    Hockaday JM; Peet KM; Hockaday TD
    Headache; 1976 Jul; 16(3):109-14. PubMed ID: 987029
    [No Abstract]   [Full Text] [Related]  

  • 45. Editorial: The many faces of bromocriptine.
    Vaisurb S
    JAMA; 1976 Jun; 235(26):2854-5. PubMed ID: 946996
    [No Abstract]   [Full Text] [Related]  

  • 46. [Endocrine effects of bromocryptin in patients with Parkinsonism].
    Barreca T; Gianrossi R; Gallamini A; Nizzo MC; Queirolo A
    Boll Soc Ital Biol Sper; 1976 Oct; 52(19):1564-7. PubMed ID: 1037379
    [No Abstract]   [Full Text] [Related]  

  • 47. Pergolide-induced circling in rats with 6-hydroxydopamine lesions in the nigrostriatal pathway.
    Duvoisin RC; Heikkila RE; Manzino L
    Neurology; 1982 Dec; 32(12):1387-91. PubMed ID: 6128698
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Dopaminergic agonists in Parkinsonism.
    Claveria LE; Teychenne PF; Calne DB; Petrie A; Bassendine MF
    Adv Neurol; 1975; 9():383-92. PubMed ID: 1096576
    [No Abstract]   [Full Text] [Related]  

  • 49. Dystonia-Parkinson syndrome: differential effects of levodopa and dopamine agonists.
    Klawans HL; Paleologos N
    Clin Neuropharmacol; 1986; 9(3):298-302. PubMed ID: 3719575
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Lisuride in parkinsonism.
    Parkes JD; Schachter M; Marsden CD; Smith B; Wilson A
    Ann Neurol; 1981 Jan; 9(1):48-52. PubMed ID: 7212665
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Dopamine agonists in the treatment of Parkinson's disease.
    Rinne UK
    Adv Neurol; 1983; 37():141-50. PubMed ID: 6305175
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [The treatment of Parkinson disease using the combination bromocriptine and levodopa].
    Dufresne JJ
    Rev Med Suisse Romande; 1990 Jun; 110(6):559-64. PubMed ID: 2367793
    [No Abstract]   [Full Text] [Related]  

  • 53. Bromocriptine and lisuride in Parkinson's disease.
    Caraceni T; Giovannini P; Parati E; Scigliano G; Grassi MP; Carella F
    Adv Neurol; 1984; 40():531-5. PubMed ID: 6695632
    [No Abstract]   [Full Text] [Related]  

  • 54. Sustained bromocriptine therapy in 50 previously untreated patients with Parkinson's disease.
    Stern GM; Lees AJ
    Adv Neurol; 1983; 37():17-21. PubMed ID: 6858771
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Further experiences with low doses of bromocriptine in Parkinson's disease.
    Fahn S; Côté LJ; Barrett RE; Snider SR
    Adv Biochem Psychopharmacol; 1980; 23():255-60. PubMed ID: 7395615
    [No Abstract]   [Full Text] [Related]  

  • 56. Bromocriptine in the treatment of advanced breast cancer.
    Barrett A; Morgan L; Raggatt PR; Hobbs JR
    Clin Oncol; 1976 Dec; 2(4):373-7. PubMed ID: 1037393
    [No Abstract]   [Full Text] [Related]  

  • 57. [Experience with the use of parlodel in the treatment of Parkinson patients].
    Stoliarova LG; Kadykov AS; Shvedkov VV; Pivovarova VM
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1986; 86(2):219-22. PubMed ID: 3705825
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The role of bromocriptine in the treatment of Parkinson's disease.
    Stern GM; Lees AJ; Shaw KM; Lander CM
    Adv Biochem Psychopharmacol; 1980; 23():267-70. PubMed ID: 7395617
    [No Abstract]   [Full Text] [Related]  

  • 59. [Bromocriptine (Parlodel) in parkinsonism].
    Pakkenberg H
    Ugeskr Laeger; 1978 May; 140(22):1297. PubMed ID: 653876
    [No Abstract]   [Full Text] [Related]  

  • 60. Pleuropulmonary fibrosis due to bromocriptine treatment for Parkinson's disease.
    Todman DH; Oliver WA; Edwards RL
    Clin Exp Neurol; 1990; 27():79-82. PubMed ID: 2129961
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.